Biggest News Aggregation in the World
📰 Bertram Pitt News

Bertram Pitt News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bertram Pitt. Real-time updates on events, politics, business and more.

Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023

THE WOODLANDS, Texas, Aug. 21, 2023 -- Lexicon Pharmaceuticals, Inc. today announced that analyses of clinical study results relating to INPEFA™ , its recently approved drug for heart...
United States Ann Arbor Noord Holland Carrie Siragusa Marc Bonaca Alina Cocuzza

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cardiologists making strides in COVID-19 research

Cardiology Today | COVID-19 is predominantly considered an infectious and respiratory disease, but it is intertwined with the CV system as well. That means cardiologists have a lot to contribute to battle it, especially in the area of pathophysiology.Because COVID-19 is often considered an ICU issue and an infectious disease, cardiologists have at times been left on the sideline during the pandemic. But we now know
United States San Diego Sankt Peterburg Alans Maisel Bertram Pitt Valentin Sinitsin
Source: healio.com

Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD

/PRNewswire/ -- KBP Biosciences PTE. Ltd. ("KBP Biosciences" or the "Company"), a clinical-stage biotechnology company dedicated to research, development, and...
United States San Antonio James Mccabe University Of Chicago Medical Center American Heart Association Comprehensive Hypertension Center American Heart Association Scientific Sessions

KBP Biosciences: Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD

Hepatic Impairment and Drug-Drug Interaction Study Results Presented PRINCETON, N.J., Jan. 6, 2023 /PRNewswire/ -- KBP Biosciences PTE. Ltd. ("KBP Biosciences" or the "Company"), a clinical-stage
United States San Antonio Kostenloser Wertpapierhandel James Mccabe University Of Chicago Medical Center American Heart Association Comprehensive Hypertension Center

Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD

Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD - read this article along with other careers information, tips and advice on BioSpace
United States San Antonio James Mccabe University Of Chicago Medical Center American Heart Association Comprehensive Hypertension Center American Heart Association Scientific Sessions

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science